Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with

Margaret Strieper1, Peter Karpawich, Patrick Frias

  • 1Sibley Heart Center, Children's Healthcare of Atlanta at Emory University, Atlanta, Georgia 30329, USA. strieperp@kidsheart.com <strieperp@kidsheart.com>

Insights

Cardiac resynchronization therapy (CRT) shows early promise for young patients with congenital heart disease and ventricular dysfunction. This study explores its long-term use in this population.

Area of Science:

  • Pediatric Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • Limited data exist on cardiac resynchronization therapy (CRT) in pediatric populations.
  • Previous studies suggest acute benefits of CRT in young patients with specific post-surgical complications.
  • No published data address the long-term management of systemic ventricular dysfunction in young patients with congenital heart disease using CRT.

Purpose of the Study:

  • To describe the initial experience with CRT for long-term management of systemic ventricular dysfunction in pediatric patients with congenital heart disease.
  • To evaluate the efficacy and safety of CRT in this specific, understudied population.

Main Methods:

  • Retrospective analysis of pediatric patients with congenital heart disease receiving CRT.
  • Assessment of clinical outcomes, including New York Heart Association classification, aerobic capacity, and ventricular contractility.
  • Evaluation of device performance and adverse events.

Main Results:

  • Early promising results in a young patient with congenital heart disease showed improvements in functional status and cardiac function post-CRT.
  • Previous reports indicate acute benefits in young patients with postoperative right bundle branch block.
  • This report details initial findings on the long-term application of CRT in this cohort.

Conclusions:

  • Cardiac resynchronization therapy may offer a viable long-term management strategy for young patients with congenital heart disease and systemic ventricular dysfunction.
  • Further research is warranted to confirm long-term efficacy and safety in this population.
  • CRT represents a potential therapeutic option for improving quality of life and cardiac function in pediatric patients with complex heart conditions.